These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28304150)
1. Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers. Engineer R; Ostwal V; Arya S; Gupta P; Chopra S; Patil P; Jatal S; Saklani A Asia Pac J Clin Oncol; 2017 Aug; 13(4):322-328. PubMed ID: 28304150 [TBL] [Abstract][Full Text] [Related]
2. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy. Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941 [TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer. Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339 [TBL] [Abstract][Full Text] [Related]
5. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174 [TBL] [Abstract][Full Text] [Related]
6. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence. Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer. Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358 [TBL] [Abstract][Full Text] [Related]
9. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy. Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196 [TBL] [Abstract][Full Text] [Related]
10. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study. Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J; Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845 [TBL] [Abstract][Full Text] [Related]
12. Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus. Kulaylat AS; Hollenbeak CS; Stewart DB Dis Colon Rectum; 2017 Sep; 60(9):922-927. PubMed ID: 28796730 [TBL] [Abstract][Full Text] [Related]
13. Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia. Kim KH; Park MJ; Lim JS; Kim NK; Min BS; Ahn JB; Kim TI; Kim HG; Koom WS Jpn J Clin Oncol; 2016 Apr; 46(4):316-22. PubMed ID: 26802164 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study. Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932 [TBL] [Abstract][Full Text] [Related]
15. Chemoradiotherapy with Concurrent Regional Arterial Chemotherapy for Locally Bulky Unresectable Rectal Cancer: A Case Series. Huang W; Wu J; Liu G; Lv Y; Huang J; Li W Oncol Res Treat; 2019; 42(12):678-683. PubMed ID: 31514189 [TBL] [Abstract][Full Text] [Related]
16. Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study. Lee JH; Chie EK; Jeong SY; Kim TY; Kim DY; Kim TH; Kim SY; Baek JY; Chang HJ; Kim MJ; Park SC; Oh JH; Kim SH; Lee JH; Choi DH; Park HC; Kang SB; Kim JS Cancer Res Treat; 2018 Apr; 50(2):506-517. PubMed ID: 28546522 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer. Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results. Guimas V; Boustani J; Schipman B; Lescut N; Puyraveau M; Bosset JF; Servagi-Vernat S Drugs Aging; 2016 Jun; 33(6):419-25. PubMed ID: 27138958 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720 [TBL] [Abstract][Full Text] [Related]
20. The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer. Beppu N; Yoshie H; Kimura F; Aihara T; Doi H; Kamikonya N; Matsubara N; Tomita N; Yanagi H; Yamanaka N Surg Today; 2016 Oct; 46(10):1123-31. PubMed ID: 26704191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]